# Apodex 1.1 vs Qwen3.7 Max

> Side-by-side benchmark comparison for Apodex 1.1 and Qwen3.7 Max across agentic, coding, multimodal, knowledge, reasoning, multilingual, and math tasks.

- Canonical page: https://benchlm.ai/compare/apodex-1-1-vs-qwen3-7-max
- Last updated: October 9, 2026

- Shared sourced benchmarks: 3
- HTML indexing: indexable
- Ranking lane: BenchAlign v5.8

## Quick Verdict

Evidence is too thin for a benchmark verdict: Apodex 1.1 and Qwen3.7 Max share only 3 sourced benchmark rows.

## Summary

- Only 3 shared sourced benchmark rows are available. That is not enough for a broad capability verdict, so this mirror does not name an overall winner.
- Qwen3.7 Max has the larger published context window at 1M.

## Model Snapshot

| Property | Apodex 1.1 | Qwen3.7 Max |
|----------|----------|----------|
| Creator | Apodex | Alibaba |
| Type | Proprietary | Proprietary |
| Reasoning | Reasoning | Reasoning |
| Context | N/A | 1M |
| Independent public score (not head-to-head) | 50.64 | 62.65 |
| Benchmarks Covered | 10 | 41 |
| Pricing (input/output) | Pricing unavailable / Pricing unavailable | Pricing unavailable / Pricing unavailable |

## Category Breakdown

### Agentic

- Winner: Insufficient shared evidence
- Apodex 1.1 public-lane score: 45.4 (Estimated · #52/122)
- Qwen3.7 Max public-lane score: 39.6 (Supported · #63/122)

| Benchmark | Apodex 1.1 | Qwen3.7 Max | Winner |
|-----------|-----------|-----------|--------|
| Terminal-Bench 2.1 | 70.8% | Coming soon | Coming soon |
| HLE w/ tools | 56.1% | 53.5% | Apodex 1.1 |
| APEX-Agents | 38.5% | Coming soon | Coming soon |
| DeepSearchQA | 92.4% | Coming soon | Coming soon |
| Terminal-Bench 2.0 | Coming soon | 69.7% | Coming soon |
| QwenClawBench | Coming soon | 64.3% | Coming soon |
| Claw-Eval | Coming soon | 65.2% | Coming soon |
| BFCL v4 | Coming soon | 75.0% | Coming soon |
| MCP Atlas | Coming soon | 76.4% | Coming soon |
| VITA-Bench | Coming soon | 47.9% | Coming soon |
| Gert Labs | Coming soon | 64.27% | Coming soon |
| ResearchClawBench | Coming soon | 18.7% | Coming soon |
| Terminal-Bench 2.1 (Vals) | Coming soon | 61.0% | Coming soon |

### Coding

- Winner: Insufficient shared evidence
- Apodex 1.1 public-lane score: 42.7 (Estimated · #59/146)
- Qwen3.7 Max public-lane score: 44.9 (Supported · #52/146)

| Benchmark | Apodex 1.1 | Qwen3.7 Max | Winner |
|-----------|-----------|-----------|--------|
| Terminal-Bench 2.1 | 70.8% | Coming soon | Coming soon |
| SWE-bench Verified | 77.7% | 80.4% | Qwen3.7 Max |
| SWE-bench Pro | Coming soon | 60.6% | Coming soon |
| SWE Multilingual | Coming soon | 78.3% | Coming soon |
| NL2Repo | Coming soon | 47.2% | Coming soon |
| SciCode | Coming soon | 53.5% | Coming soon |
| LiveCodeBench | Coming soon | 91.6% | Coming soon |
| Terminal-Bench 2.0 | Coming soon | 69.7% | Coming soon |
| OpenHarmony Bench | Coming soon | 53.4% | Coming soon |
| LiveCodeBench (Vals) | Coming soon | 87.1% | Coming soon |
| SWE-bench (Vals) | Coming soon | 68.8% | Coming soon |

### Reasoning

- Winner: Insufficient shared evidence
- Apodex 1.1 public-lane score: 76.8 (Unranked · 2 rankable rows)
- Qwen3.7 Max public-lane score: 76.3 (Unranked · 3 rankable rows)

| Benchmark | Apodex 1.1 | Qwen3.7 Max | Winner |
|-----------|-----------|-----------|--------|
| MRCRv2 | Coming soon | 90.4% | Coming soon |
| CritPt | Coming soon | 13.4% | Coming soon |

### Multimodal & Grounded

- Winner: Insufficient shared evidence
- Apodex 1.1 public-lane score: 77.7 (Unranked · 1 rankable row)
- Qwen3.7 Max public-lane score: Coming soon

### Knowledge

- Winner: Insufficient shared evidence
- Apodex 1.1 public-lane score: 53.5 (Supported · #59/174)
- Qwen3.7 Max public-lane score: 59.7 (Supported · #42/174)

| Benchmark | Apodex 1.1 | Qwen3.7 Max | Winner |
|-----------|-----------|-----------|--------|
| HLE | 56.1% | 41.4% | Apodex 1.1 |
| FrontierScience Research | 63.3% | Coming soon | Coming soon |
| BioMysteryBench (human-difficult) | 35.3% | Coming soon | Coming soon |
| GPQA | Coming soon | 92.4% | Coming soon |
| GPQA-D | Coming soon | 92.4% | Coming soon |
| MMLU-Pro | Coming soon | 89.6% | Coming soon |
| MMLU-Redux | Coming soon | 95% | Coming soon |
| SuperGPQA | Coming soon | 73.6% | Coming soon |
| MMMLU | Coming soon | 90.3% | Coming soon |
| GPQA Diamond (Vals) | Coming soon | 90.2% | Coming soon |
| MMLU-Pro (Vals) | Coming soon | 89.3% | Coming soon |

### Multilingual

- Winner: Insufficient shared evidence
- Apodex 1.1 public-lane score: Coming soon
- Qwen3.7 Max public-lane score: 100 (#1/16)

| Benchmark | Apodex 1.1 | Qwen3.7 Max | Winner |
|-----------|-----------|-----------|--------|
| MMLU-ProX | Coming soon | 87% | Coming soon |
| NOVA-63 | Coming soon | 59.0% | Coming soon |
| INCLUDE | Coming soon | 86.2% | Coming soon |
| MAXIFE | Coming soon | 89.2% | Coming soon |
| PolyMath | Coming soon | 86.5% | Coming soon |

### Instruction Following

- Winner: Insufficient shared evidence
- Apodex 1.1 public-lane score: Coming soon
- Qwen3.7 Max public-lane score: 89.2 (#17/125)

| Benchmark | Apodex 1.1 | Qwen3.7 Max | Winner |
|-----------|-----------|-----------|--------|
| IFEval | Coming soon | 94.3% | Coming soon |
| IFBench | Coming soon | 79.1% | Coming soon |

### Mathematics

- Winner: Insufficient shared evidence
- Apodex 1.1 public-lane score: Coming soon
- Qwen3.7 Max public-lane score: 81.9 (Unranked · 3 rankable rows)

| Benchmark | Apodex 1.1 | Qwen3.7 Max | Winner |
|-----------|-----------|-----------|--------|
| IMO 2026 | 31/42 | Coming soon | Coming soon |
| HMMT Feb 2026 | Coming soon | 97.1% | Coming soon |
| IMOAnswerBench | Coming soon | 90.0% | Coming soon |
| Apex | Coming soon | 44.5% | Coming soon |

## FAQ

### Is there enough evidence to pick between Apodex 1.1 and Qwen3.7 Max?

Not yet. The models share only 3 sourced benchmark rows, so this mirror reports the available measurements and metadata without naming a broad winner.

### What can I compare safely on this page?

Published pricing, context windows, model type, and individual shared benchmark rows are directly comparable. Independent overall scores and non-overlapping benchmark coverage are labeled separately and should not be read as a controlled head-to-head result.

## Related Comparisons

- [Apodex 1.1 vs Apodex 1.1 Mini](/compare/apodex-1-1-vs-apodex-1-1-mini)
- [Qwen3.7 Max vs Apodex 1.1 Mini](/compare/apodex-1-1-mini-vs-qwen3-7-max)
- [Apodex 1.1 vs Claude Opus 5.5](/compare/apodex-1-1-vs-claude-opus-5-5)
- [Qwen3.7 Max vs Claude Opus 5.5](/compare/claude-opus-5-5-vs-qwen3-7-max)

## Explore More

- [Apodex 1.1 profile](/models/apodex-1-1)
- [Qwen3.7 Max profile](/models/qwen3-7-max)
- [Compare Pricing](/llm-pricing)
- [Alternative Finder](/tools/alternative-finder)
- [LLM Selector](/tools/llm-selector)
- [Overall Rankings](/best/overall)